Chemosphere 297 , 134132 (2022)
Washington, DC: Politics and Prose Publishing
Medical Conditions & Medications: Patients with certain conditions, such as gastroesophageal reflux disease (GERD), or those taking specific medications like Vitamin D3 supplements, may have an elevated risk of experiencing eye color changes
Regulatory Status Compound FDA Status Availability CJC-1295 (No DAC) Not approved Research use only CJC-1295 (with DAC) Not approved Research use only Ipamorelin Not approved Research use only CJC-1295 + Ipamorelin Combo Not approved Research use only None of these compounds have received FDA approval for therapeutic use
This distinction is required on the labels of research chemicals, and is what exempts them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR)
por razones obvias de higiene y seguridad